Evidence map›Paper›PMID 30265441›Full record

ArticleChemSusChem2019

NAD

Fabio Tonin, Linda G Otten, Isabel W C E Arends

Open access · hybridAbstract read
In one paragraph

Article in ChemSusChem, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Site-Directed Mutagenesis Increased the Catalytic Activity and Stability ofInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Biological synthesis of ursodeoxycholic acid.Frontiers in microbiology · 2023
    Review
  9. Recent trends in biocatalysis.Chemical Society reviews · 2021
    Review
  10. Article
  11. Article
  12. NADChemSusChem · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Fabio ToninDepartment of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629, HZ, Delft, The Netherlands.ORCID http://orcid.org/0000-0002-5358-5271
Linda G OttenDepartment of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629, HZ, Delft, The Netherlands.
Isabel W C E ArendsDepartment of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629, HZ, Delft, The Netherlands.ORCID http://orcid.org/0000-0002-1015-4682
Delft University of Technology · NLUtrecht University · NL

Funding

European Union - Horizon 2020 737266
6 · The paper itself

Abstract

Epimerization of cholic and chenodeoxycholic acid (CA and CDCA, respectively) is a notable conversion for the production of ursodeoxycholic acid (UDCA). Two enantiocomplementary hydroxysteroid dehydrogenases (7α- and 7β-HSDHs) can carry out this transformation fully selectively by specific oxidation of the 7α-OH group of the substrate and subsequent reduction of the keto intermediate to the final product (7β-OH). With a view to developing robust and active biocatalysts, novel NADH-active 7β-HSDH species are necessary to enable a solely NAD

Indexed as

BiocatalysisBiotransformationChenodeoxycholic AcidCholic AcidClostridiumHydrogen-Ion ConcentrationHydroxysteroid DehydrogenasesKineticsLactobacillusNADOxidation-ReductionStenotrophomonas maltophiliaTemperature7 alpha-hydroxysteroid dehydrogenase7 beta-hydroxysteroid dehydrogenaseChenodeoxycholic AcidCholic AcidHydroxysteroid DehydrogenasesNADbiotransformationcarboxylic acidscofactorsenzymessteroids

Identifiers

PMID30265441
PMCPMC6681466
OpenAlexW2894016122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.